Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Carlo Colosimo »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Carles Vilari O-Güell < Carlo Colosimo < Carlo Ferrarese  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000108 (2012) Florian Krismer [Autriche] ; Klaus Seppi [Autriche] ; François Tison [France] ; Cristina Sampaio [Portugal] ; Anja Zangerl [Autriche] ; Cecilia Peralta [Autriche, Argentine] ; Farid Yekhlef [France] ; Imad Ghorayeb [France] ; Fabienne Ory-Magne [France] ; Monique Galitzky [France] ; Maria Bozi [Royaume-Uni] ; Tommaso Scaravilli [Royaume-Uni, Italie] ; Carlo Colosimo [Italie] ; Felix Geser [Autriche, Allemagne] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Greqor K. Wenning [Autriche]The Unified Multiple System Atrophy Rating Scale: Intrarater Reliability
000190 (2010) Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis]Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations
000202 (2010) Martin Köllensperger [Autriche] ; Felix Geser [Autriche] ; Jean-Pierre Ndayisaba [Autriche] ; Sylvia Boesch [Autriche] ; Klaus Seppi [Autriche] ; Karen Ostergaard [Danemark] ; Erik Dupont [Danemark] ; A. Cardozo [Espagne] ; Eduardo Tolosa [Espagne] ; Michael Abele [Allemagne] ; Thomas Klockgether [Allemagne] ; Farid Yekhlef [France] ; Francois Tison [France] ; Christine Daniels [Allemagne] ; Günther Deuschl [Allemagne] ; Miguel Coelho [Portugal] ; Cristina Sampaio [Portugal] ; Maria Bozi [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Anette Schrag [Royaume-Uni] ; Chris J. Mathias [Royaume-Uni] ; Clare Fowler [Royaume-Uni] ; Christer F. Nilsson [Suède] ; H Kan Widner [Suède] ; Nicole Schimke [Allemagne] ; Wolfgang Oertel [Allemagne] ; Francesca Del Sorbo [Italie] ; Alberto Albanese [Italie] ; Maria Teresa Pellecchia [Italie] ; Paolo Barone [Italie] ; Ruth Djaldetti [Israël] ; Carlo Colosimo [Italie] ; Giuseppe Meco [Italie] ; Antonio Gonzalez-Mandly [Espagne] ; Jose Berciano [Espagne] ; Tanya Gurevich [Israël] ; Nir Giladi [Israël] ; Monique Galitzky [France] ; Olivier Rascol [France] ; Christoph Kamm [Allemagne] ; Thomas Gasser [Allemagne] ; Uwe Siebert [Autriche, États-Unis] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry
000436 (2004) Gregor K. Wenning [Autriche] ; Franc Ois Tison [France] ; Klaus Seppi [Autriche] ; Cristina Sampaio [Portugal] ; Anja Diem [Autriche] ; Farid Yekhlef [France] ; Imad Ghorayeb [France] ; Fabienne Ory [France] ; Monique Galitzky [France] ; Tommaso Scaravilli [Royaume-Uni] ; Maria Bozi [Royaume-Uni] ; Carlo Colosimo [Italie] ; Sid Gilman [États-Unis] ; Clifford W. Shults [États-Unis] ; Niall P. Quinn [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche]Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)
000512 (2001) Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease

List of associated KwdEn.i

Nombre de
documents		Descripteur
4Humans
4Nervous system diseases
3Multiple system atrophy
2Age of Onset
2Diagnosis
2Disability Evaluation
2Evaluation scale
2Female
2Male
2Multiple System Atrophy (diagnosis)
2Multiple System Atrophy (physiopathology)
2Parkinson disease
2Questionnaires
2Recommendation
2Reliability
2Reproducibility of Results
2Severity of Illness Index
1Activities of Daily Living
1Agonist
1Antiparkinson Agents (therapeutic use)
1Antiparkinson agent
1Apomorphine (administration & dosage)
1Apomorphine (diagnostic use)
1Apomorphine (pharmacology)
1Autonomic Nervous System (physiopathology)
1Cerebellar Ataxia (diagnosis)
1Cerebellar Ataxia (epidemiology)
1Cerebellar Ataxia (physiopathology)
1Chemotherapy
1Clinical management
1Consensus conference
1Corpus Striatum (drug effects)
1Decision Making
1Domperidone (administration & dosage)
1Domperidone (diagnostic use)
1Domperidone (pharmacology)
1Dopamine Agonists (administration & dosage)
1Dopamine Agonists (diagnostic use)
1Dopamine Agonists (pharmacology)
1Dopamine Antagonists (administration & dosage)
1Dopamine Antagonists (diagnostic use)
1Dopamine Antagonists (pharmacology)
1Dopamine agonist
1Dopamine receptor
1Drug Administration Schedule
1Dyskinesia
1Dyskinesia, Drug-Induced (diagnosis)
1Dyskinesia, Drug-Induced (etiology)
1EMSA‐SG
1Erectile Dysfunction (epidemiology)
1Europe
1Evaluation Studies as Topic
1Force
1Guidelines as Topic
1Human
1Hypotension, Orthostatic (diagnosis)
1Hypotension, Orthostatic (epidemiology)
1Hypotension, Orthostatic (physiopathology)
1Levodopa
1Levodopa (administration & dosage)
1Levodopa (diagnostic use)
1Levodopa (pharmacology)
1Levodopa (therapeutic use)
1Middle Aged
1Multiple System Atrophy (epidemiology)
1Multiple System Atrophy (therapy)
1Observer Variation
1Parkinson Disease (diagnosis)
1Parkinson Disease (drug therapy)
1Parkinson's disease
1Parkinsonian Disorders (diagnosis)
1Parkinsonian Disorders (drug therapy)
1Parkinsonian Disorders (epidemiology)
1Parkinsonian Disorders (physiopathology)
1Pharmacologic test
1Psychometrics
1Registries
1Shy-Drager Syndrome (diagnosis)
1Shy-Drager Syndrome (physiopathology)
1Speech Disorders (epidemiology)
1Substantia Nigra (drug effects)
1Time Factors
1Treatment
1Unified Multiple System Atrophy Rating Scale
1Urinary Incontinence (epidemiology)
1Urinary Retention (epidemiology)
1Validation
1Validity
1apomorphine
1clinimetrics
1diagnosis
1dyskinesia
1internal consistency
1interrater reliability
1levodopa
1multiple system atrophy
1natural history
1rating scales
1reliability
1treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Carlo Colosimo" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Carlo Colosimo" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Carlo Colosimo
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024